-
1
-
-
77950233673
-
A fresh look at NASH pathogenesis. Part 1: the metabolic movers
-
Larter C.Z., Chitturi S., Farrell G.C. A fresh look at NASH pathogenesis. Part 1: the metabolic movers. J Gastroenterol Hepatol 2010, 25:672-690.
-
(2010)
J Gastroenterol Hepatol
, vol.25
, pp. 672-690
-
-
Larter, C.Z.1
Chitturi, S.2
Farrell, G.C.3
-
2
-
-
84859404868
-
Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications
-
Cusi K. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications. Gastroenterology 2012, 142:711-725.
-
(2012)
Gastroenterology
, vol.142
, pp. 711-725
-
-
Cusi, K.1
-
3
-
-
84877585029
-
NAFLD in Asia-as common and important as in the West
-
Farrell G.C., Wong V.W., Chitturi S. NAFLD in Asia-as common and important as in the West. Nat Rev Gastro Hep 2013, 10:307-318.
-
(2013)
Nat Rev Gastro Hep
, vol.10
, pp. 307-318
-
-
Farrell, G.C.1
Wong, V.W.2
Chitturi, S.3
-
4
-
-
84865545850
-
Association between diabetes, family history of diabetes and risk of non-alcoholic steatohepatitis and fibrosis
-
Loomba R., Abraham M., Unalp A., et al. Association between diabetes, family history of diabetes and risk of non-alcoholic steatohepatitis and fibrosis. Hepatology 2012, 56:943-951.
-
(2012)
Hepatology
, vol.56
, pp. 943-951
-
-
Loomba, R.1
Abraham, M.2
Unalp, A.3
-
5
-
-
84861332191
-
Non-high-density lipoprotein cholesterol as a biomarker for non-alcoholic steatohepatitis
-
Corey K.E., Lai M., Gelrud L.G., et al. Non-high-density lipoprotein cholesterol as a biomarker for non-alcoholic steatohepatitis. Clin Gastroenterol Hepatol 2012, 10:651-656.
-
(2012)
Clin Gastroenterol Hepatol
, vol.10
, pp. 651-656
-
-
Corey, K.E.1
Lai, M.2
Gelrud, L.G.3
-
6
-
-
22344452893
-
The natural history of nonalcoholic fatty liver disease: a population-based cohort study
-
Adams L.A., Lymp J.F., St Sauver J., et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005, 129:113-121.
-
(2005)
Gastroenterology
, vol.129
, pp. 113-121
-
-
Adams, L.A.1
Lymp, J.F.2
St Sauver, J.3
-
7
-
-
84862517200
-
Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD)
-
Musso G., Cassader M., Rosina F., et al. Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD). Diabetologia 2012, 55:885-904.
-
(2012)
Diabetologia
, vol.55
, pp. 885-904
-
-
Musso, G.1
Cassader, M.2
Rosina, F.3
-
8
-
-
78649890465
-
Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Artorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis
-
Athyros V.G., Tziomalos K., Gossios T.D., et al. Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Artorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis. Lancet 2010, 376:1916-1922.
-
(2010)
Lancet
, vol.376
, pp. 1916-1922
-
-
Athyros, V.G.1
Tziomalos, K.2
Gossios, T.D.3
-
9
-
-
33645888317
-
National Lipid Association Statin Safety Task Force Liver Expert Panel. An assessment of statin safety by hepatologists
-
Cohen D.E., Anania F.A., Chalasani N. National Lipid Association Statin Safety Task Force Liver Expert Panel. An assessment of statin safety by hepatologists. Am J Cardiol 2006, 97:77C-81C.
-
(2006)
Am J Cardiol
, vol.97
-
-
Cohen, D.E.1
Anania, F.A.2
Chalasani, N.3
-
10
-
-
77955690182
-
Hepatic lipotoxicity and pathogenesis of nonalcoholic steato-hepatitis: the central role of nontriglyceride fatty acid metabolites
-
Neuschwander-Tetri B.A. Hepatic lipotoxicity and pathogenesis of nonalcoholic steato-hepatitis: the central role of nontriglyceride fatty acid metabolites. Hepatology 2010, 52:774-788.
-
(2010)
Hepatology
, vol.52
, pp. 774-788
-
-
Neuschwander-Tetri, B.A.1
-
11
-
-
56649094325
-
Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease
-
Malhi H., Gores G. Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease. Semin Liver Dis 2008, 28:360-369.
-
(2008)
Semin Liver Dis
, vol.28
, pp. 360-369
-
-
Malhi, H.1
Gores, G.2
-
12
-
-
36349024819
-
A lipidomic analysis of nonalcoholic fatty liver disease
-
Puri P., Baillie R.A., Wiest M.M., et al. A lipidomic analysis of nonalcoholic fatty liver disease. Hepatology 2007, 46:1081-1090.
-
(2007)
Hepatology
, vol.46
, pp. 1081-1090
-
-
Puri, P.1
Baillie, R.A.2
Wiest, M.M.3
-
13
-
-
61849095626
-
Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH
-
Caballero F., Fernández A., De Lacy A.M., et al. Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH. JHepatol 2009, 50:789-796.
-
(2009)
JHepatol
, vol.50
, pp. 789-796
-
-
Caballero, F.1
Fernández, A.2
De Lacy, A.M.3
-
14
-
-
49649110937
-
Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis
-
Wouters K., van Gorp P.J., Bieghs V., et al. Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis. Hepatology 2008, 48:474-486.
-
(2008)
Hepatology
, vol.48
, pp. 474-486
-
-
Wouters, K.1
van Gorp, P.J.2
Bieghs, V.3
-
16
-
-
84861563506
-
Beyond reasonable doubt: who is the culprit in lipotoxicity in NAFLD/NASH?
-
Arteel G.E. Beyond reasonable doubt: who is the culprit in lipotoxicity in NAFLD/NASH?. Hepatology 2012, 55:2030-2032.
-
(2012)
Hepatology
, vol.55
, pp. 2030-2032
-
-
Arteel, G.E.1
-
17
-
-
80053612479
-
Hepatic free cholesterol accumulates in obese, diabetic mice and causes nonalcoholic steatohepatitis
-
Van Rooyen D.M., Larter C.Z., Haigh W.G., et al. Hepatic free cholesterol accumulates in obese, diabetic mice and causes nonalcoholic steatohepatitis. Gastroenterology 2011, 141:1393-1403.
-
(2011)
Gastroenterology
, vol.141
, pp. 1393-1403
-
-
Van Rooyen, D.M.1
Larter, C.Z.2
Haigh, W.G.3
-
18
-
-
84860469242
-
Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease
-
Min H.K., Kapoor A., Fuchs M., et al. Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease. Cell Metab 2012, 15:665-674.
-
(2012)
Cell Metab
, vol.15
, pp. 665-674
-
-
Min, H.K.1
Kapoor, A.2
Fuchs, M.3
-
19
-
-
84879132692
-
Pharmacological cholesterol lowering reverses fibrotic NASH in obese, diabetic mice
-
Van Rooyen D.M., Gan L.T., Yeh M.M., et al. Pharmacological cholesterol lowering reverses fibrotic NASH in obese, diabetic mice. J Hepatol 2013, 59:144-152.
-
(2013)
J Hepatol
, vol.59
, pp. 144-152
-
-
Van Rooyen, D.M.1
Gan, L.T.2
Yeh, M.M.3
-
20
-
-
36348935003
-
Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet
-
Matsuzawa N., Takamura T., Kurita S., et al. Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet. Hepatology 2007, 46:1392-1403.
-
(2007)
Hepatology
, vol.46
, pp. 1392-1403
-
-
Matsuzawa, N.1
Takamura, T.2
Kurita, S.3
-
21
-
-
77954601497
-
A human-type non-alcoholic steatohepatitis model with advanced fibrosis in rabbits
-
Ogawa T., Fujii H., Yoshizato K., et al. A human-type non-alcoholic steatohepatitis model with advanced fibrosis in rabbits. Am J Pathol 2010, 177:153-165.
-
(2010)
Am J Pathol
, vol.177
, pp. 153-165
-
-
Ogawa, T.1
Fujii, H.2
Yoshizato, K.3
-
22
-
-
80055026523
-
Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition
-
Charlton M., Krishnan A., Viker K., et al. Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition. Am J Physiol Gastrointest Liver Physiol 2011, 301:G825-G834.
-
(2011)
Am J Physiol Gastrointest Liver Physiol
, vol.301
-
-
Charlton, M.1
Krishnan, A.2
Viker, K.3
-
23
-
-
84866736015
-
Dietary trans-fatty acid induced NASH is normalized following loss of trans-fatty acids from hepatic lipid pools
-
Neuschwander-Tetri B.A., Ford D.A., Acharya S., et al. Dietary trans-fatty acid induced NASH is normalized following loss of trans-fatty acids from hepatic lipid pools. Lipids 2012, 47:941-950.
-
(2012)
Lipids
, vol.47
, pp. 941-950
-
-
Neuschwander-Tetri, B.A.1
Ford, D.A.2
Acharya, S.3
-
24
-
-
77956634470
-
High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma co-enzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis
-
Kohli R., Kirby M., Xanthakos S.A., et al. High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma co-enzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis. Hepatology 2010, 52:934-944.
-
(2010)
Hepatology
, vol.52
, pp. 934-944
-
-
Kohli, R.1
Kirby, M.2
Xanthakos, S.A.3
-
25
-
-
33845872811
-
In vivo responsiveness to ezetimibe correlates with Niemann-Pick C1-like-1 (NPC1L1) binding affinity: comparison of multiple species NPC1L1 orthologs
-
Hawas B.E., O'Neill K.A., Yao X., et al. In vivo responsiveness to ezetimibe correlates with Niemann-Pick C1-like-1 (NPC1L1) binding affinity: comparison of multiple species NPC1L1 orthologs. Mol Pharm 2007, 71:19-29.
-
(2007)
Mol Pharm
, vol.71
, pp. 19-29
-
-
Hawas, B.E.1
O'Neill, K.A.2
Yao, X.3
-
26
-
-
84886142392
-
Lipid modifiers and NASH: statins, ezetimibe, fibrates, and other agents
-
Wiley-Blackwell, Oxford, G.C. Farrell, A.J. McCullough, C.P. Day (Eds.)
-
Musso G., Molinaro F., Paschetta E., et al. Lipid modifiers and NASH: statins, ezetimibe, fibrates, and other agents. Non-alcoholic fatty liver disease: a practical guide 2013, 293-307. Wiley-Blackwell, Oxford. G.C. Farrell, A.J. McCullough, C.P. Day (Eds.).
-
(2013)
Non-alcoholic fatty liver disease: a practical guide
, pp. 293-307
-
-
Musso, G.1
Molinaro, F.2
Paschetta, E.3
-
27
-
-
33750606061
-
Long-term follow-up of patients with NAFLD and elevated liver enzymes
-
Ekstedt M., Franzen L.E., Mathiesen U.L., et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 2006, 44:865-873.
-
(2006)
Hepatology
, vol.44
, pp. 865-873
-
-
Ekstedt, M.1
Franzen, L.E.2
Mathiesen, U.L.3
-
28
-
-
78651473467
-
Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease
-
Park H., Shima T., Yamaguchi K., et al. Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease. J Gastroenterol 2011, 46:101-107.
-
(2011)
J Gastroenterol
, vol.46
, pp. 101-107
-
-
Park, H.1
Shima, T.2
Yamaguchi, K.3
-
29
-
-
84880664792
-
Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and non-alcoholic fatty liver disease
-
Mudaliar S., Henry R.R., Sanyal A.J., et al. Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and non-alcoholic fatty liver disease. Gastroenterology 2013, 145:574-582.
-
(2013)
Gastroenterology
, vol.145
, pp. 574-582
-
-
Mudaliar, S.1
Henry, R.R.2
Sanyal, A.J.3
|